Windmill Cardiovascular Systems
Private Company
Funding information not available
Overview
Windmill Cardiovascular Systems is an innovative, clinical-stage medical device company pioneering a next-generation ventricular assist device (VAD) platform called TORVAD. Its unique two-piston, toroidal pump design aims to address key limitations of current continuous-flow VADs by providing synchronous, pulsatile support with significantly lower blood trauma. Led by a seasoned team with deep cardiovascular expertise, the company is advancing its platform for full, partial, and pediatric support indications, targeting a large and growing heart failure market. Windmill represents a high-potential, high-risk venture in the advanced heart failure therapy space.
Technology Platform
TORVAD (Toroidal Ventricular Assist Device): A two-piston, positive displacement pump in a toroidal chamber that provides synchronous, pulsatile blood flow with low shear stress and integrated physiological sensing.
Opportunities
Risk Factors
Competitive Landscape
The durable LVAD market is a high-barrier duopoly dominated by Abbott's HeartMate 3. Windmill's primary competition is this established standard of care. Its differentiation is based on fundamental pump mechanics (pulsatile, low-shear vs. continuous-flow) aimed at reducing major adverse events, a key battleground in the field.